BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22072919)

  • 1. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma.
    Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
    Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M
    Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma.
    Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B
    PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors.
    Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway.
    Liu J; Lin B; Hao Y; Qi Y; Zhu L; Li F; Liu D; Cong J; Zhang S; Iwamori M
    J Exp Clin Cancer Res; 2009 Dec; 28(1):154. PubMed ID: 20003467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma.
    Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M
    Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers.
    Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B
    Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in docetaxel-resistance of ovarian carcinoma-derived RMG-1 cells with enhanced expression of Lewis Y antigen.
    Zhang F; Liu J; Lin B; Liu Q; Zhao Y; Zhu L; Hao Y; Zhang S; Iwamori M
    Int J Mol Sci; 2011; 12(11):7323-34. PubMed ID: 22174601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis.
    Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B
    Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
    Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
    Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them.
    Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B
    Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells.
    Yan L; Lin B; Gao L; Gao S; Liu C; Wang C; Wang Y; Zhang S; Iwamori M
    Int J Mol Sci; 2010 Nov; 11(11):4441-52. PubMed ID: 21151448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewis y regulate cell cycle related factors in ovarian carcinoma cell RMG-I in vitro via ERK and Akt signaling pathways.
    Liu D; Liu J; Lin B; Liu S; Hou R; Hao Y; Liu Q; Zhang S; Iwamori M
    Int J Mol Sci; 2012; 13(1):828-839. PubMed ID: 22312289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.
    Hao Y; Zhu L; Yan L; Liu J; Liu D; Gao N; Tan M; Gao S; Lin B
    Oncol Rep; 2017 Dec; 38(6):3355-3366. PubMed ID: 29130097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
    Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B
    J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transfection of alpha1, 2-fucosyltransferase gene increases the antigenic expression of Lewis y in ovarian cancer cell line RMG-I].
    Lin B; Hao YY; Wang DD; Zhu LC; Zhang SL; Saito M; Iwamori M
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):284-9. PubMed ID: 18686606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [alpha1,2-fucosyltransferase gene transfection influences on biological behavior of ovarian carcinoma-derived RMG-I cells].
    Hao YY; Lin B; Zhao Y; Zhang YH; Li FF; Diao B; Ou YL; Zhang SL
    Fen Zi Xi Bao Sheng Wu Xue Bao; 2008 Dec; 41(6):435-42. PubMed ID: 19137814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewis Y promotes growth and adhesion of ovarian carcinoma-derived RMG-I cells by upregulating growth factors.
    Li F; Lin B; Hao Y; Li Y; Liu J; Cong J; Zhu L; Liu Q; Zhang S
    Int J Mol Sci; 2010 Sep; 11(10):3748-59. PubMed ID: 21152298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lewis(y) antigen-mediated positive feedback loop induces and promotes chemotherapeutic resistance in ovarian cancer.
    Liu J; Zheng M; Qi Y; Wang H; Liu M; Liu Q; Lin B
    Int J Oncol; 2018 Oct; 53(4):1774-1786. PubMed ID: 30066907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.